Tumor induction by activated JNK occurs through deregulation of cellular growth

Cancer Letters
Ulrike E E RennefahrtJ Troppmair

Abstract

Activation of the cytoplasmic (Ras-Raf-MEK-ERK) signaling cascade was shown to be both, necessary and sufficient for transformation in vitro as well as in vivo. However, over the last years the involvement of stress-activated protein kinases (SAPKs)/Jun N-terminal kinases (JNKs), and their substrate c-Jun in the process of cellular transformation has been suggested. To dissect the mechanisms through which JNK signaling contributes to the transformation process we employed a recently generated constitutively active version of this kinase, SAPKbeta-MKK7, which behaves like a weakly transforming oncogene in vitro. Dissection of the transforming potential of oncogenic JNK demonstrates that it is sufficient for tumor induction in nude mice. In vitro studies and analysis of tumor material support the conclusion that oncogenic JNK primarily transforms through its effects on cell proliferation and tumor vascularization but does not affect cell survival.

References

Jun 1, 1990·Molecular and Cellular Biology·G HeideckerU R Rapp
Aug 1, 1987·Molecular and Cellular Biology·C Chen, H Okayama
May 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·J S GreenbergerR J Eckner
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·A B RaitanoC L Sawyers
Nov 15, 1996·Cell·H G WangJ C Reed
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·S TanakaH Hanafusa
May 15, 1997·The EMBO Journal·G A RodriguesJ Schlessinger
Nov 26, 1997·The Journal of Pathology·S A PileriB Falini
Feb 17, 1998·Oncogene·E KerkhoffU R Rapp
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
May 18, 2001·Nature·P Blume-Jensen, T Hunter
Jun 13, 2001·Oncogene·P K Vogt
Jun 13, 2001·Oncogene·W JochumE F Wagner
Aug 17, 2001·Journal of Clinical Immunology·C DongR A Flavell
Jan 16, 2002·Current Opinion in Genetics & Development·Claire R Weston, Roger J Davis
May 4, 2002·Nature Cell Biology·Eitan Shaulian, Michael Karin
Jun 1, 2002·The Journal of Biological Chemistry·Ulrike E E RennefahrtUlf R Rapp
Jul 19, 2002·Advances in Enzyme Regulation·Véronique Le MellayUlf R Rapp
Jul 26, 2002·Oncogene·Marc A AntonyakAlbert J Wong
Nov 7, 2002·Cell·Derek P BrazilBrian A Hemmings
Mar 12, 2003·Genes & Development·Norman J KennedyRoger J Davis
Mar 15, 2003·Nature Reviews. Cancer·Erkki Ruoslahti
May 8, 2003·Cell Cycle·Norman J Kennedy, Roger J Davis
May 21, 2003·Proceedings of the National Academy of Sciences of the United States of America·Kojo S J Elenitoba-JohnsonMegan S Lim
Dec 12, 2003·Nature Reviews. Cancer·Robert Eferl, Erwin F Wagner
Jan 27, 2004·The American Journal of Pathology·Antonio MartinezDolors Colomer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis